George Vlotides

1.1k total citations
25 papers, 863 citations indexed

About

George Vlotides is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, George Vlotides has authored 25 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in George Vlotides's work include Neuroendocrine Tumor Research Advances (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). George Vlotides is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). George Vlotides collaborates with scholars based in Germany, United States and United Kingdom. George Vlotides's co-authors include Шломо Мелмед, Tamar Eigler, Christoph J. Auernhammer, Kathrin Zitzmann, Stephan Brand, Burkhard Göke, Florian Kopp, Neziha Cengic, Peter R. Mertens and Odelia Cooper and has published in prestigious journals such as Endocrine Reviews, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

George Vlotides

25 papers receiving 853 citations

Peers

Countries citing papers authored by George Vlotides

Since Specialization

Citations

This map shows the geographic impact of George Vlotides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Vlotides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Vlotides more than expected).

Fields of papers citing papers by George Vlotides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Vlotides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Vlotides. The network helps show where George Vlotides may publish in the future.

Co-authorship network of co-authors of George Vlotides

This figure shows the co-authorship network connecting the top 25 collaborators of George Vlotides. A scholar is included among the top collaborators of George Vlotides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Vlotides. George Vlotides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for ‘Off-Target' Effects Not Mediated by c-Met Inhibition 2015 ·Neuroendocrinology ·(unknown), (unknown), Matilde Pia Spampatti, George Vlotides, (unknown), Gerald Spöttl, Julian Maurer, Svenja Nölting, Burkhard Göke, Christoph J. Auernhammer	17
2	Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease: FIGURE 1: 2014 ·Nephrology Dialysis Transplantation ·George Vlotides, Peter R. Mertens	29
3	Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice 2014 ·Endocrinology ·Svenja Nölting, Alessio Giubellino, Yasin Tayem, (unknown), Michael Lauseker, Petra Bullova, Jan Schovánek, Miriam R. Anver, Stephanie Fliedner, Márta Korbonits, Burkhard Göke, George Vlotides, Ashley Grossman, Karel Pacák	19
4	Anticancer effects of metformin on neuroendocrine tumor cells in vitro 2014 ·HORMONES ·George Vlotides, (unknown), Matilde Pia Spampatti, Kathrin Zitzmann, Michail Chourdakis, (unknown), Julian Maurer, (unknown), (unknown), Christoph J. Auernhammer	35
5	Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells 2013 ·International Journal of Oncology ·Kathrin Zitzmann, (unknown), George Vlotides, (unknown), Julian Maurer, Burkhard Göke, Felix Beuschlein, Christoph J. Auernhammer	28
6	The Novel Somatostatin Receptor 2/Dopamine Type 2 Receptor Chimeric Compound BIM-23A758 Decreases the Viability of Human GOT1 Midgut Carcinoid Cells 2013 ·Neuroendocrinology ·Kathrin Zitzmann, (unknown), George Vlotides, Gerald Spöttl, Shengwen Zhang, Rakesh Datta, Michael D. Culler, Burkhard Göke, Christoph J. Auernhammer	14
7	Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms 2012 ·Endocrine Related Cancer ·Kathrin Zitzmann, George Vlotides, Stephan Brand, Harald Lahm, Gerald Spöttl, Burkhard Göke, Christoph J. Auernhammer	26
8	Expression and function of ErbB receptors and ligands in the pituitary 2011 ·Endocrine Related Cancer ·Odelia Cooper, George Vlotides, Hidenori Fukuoka, Mark I. Greene, Шломо Мелмед	54
9	Hypoxia-induced VEGF production ‘RSUMEs’ in pituitary adenomas 2011 ·Endocrine Related Cancer ·Robert C. Fowkes, George Vlotides	9
10	Heregulin Regulates Prolactinoma Gene Expression 2009 ·Cancer Research ·George Vlotides, Odelia Cooper, Yen-Hao Chen, (unknown), Yona Greenman, Шломо Мелмед	25
11	Fibroblast Growth Factor-2 Autofeedback Regulation in Pituitary Folliculostellate TtT/GF Cells 2009 ·Endocrinology ·George Vlotides, Yen-Hao Chen, Tamar Eigler, (unknown), Шломо Мелмед	16
12	Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor Ligands 2008 ·Cancer Research ·George Vlotides, Emily Siegel, Inês Donangelo, (unknown), Song-Guang Ren, Шломо Мелмед	59
13	PI(3)K–Akt–mTOR pathway as a potential therapeutic target in neuroendocrine tumors 2008 ·Expert Review of Endocrinology & Metabolism ·Kathrin Zitzmann, George Vlotides, Burkhard Göke, Christoph J. Auernhammer	4
14	Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells 2007 ·American Journal of Physiology-Cell Physiology ·Tamar Rubinek, Vera Chesnokova, Ido Wolf, Kolja Wawrowsky, George Vlotides, Шломо Мелмед	13
15	Anterior pituitary hormone replacement therapy—a clinical review 2007 ·Pituitary ·Christoph J. Auernhammer, George Vlotides	12
16	Mechanisms for Growth Factor-Induced Pituitary Tumor Transforming Gene-1 Expression in Pituitary Folliculostellate TtT/GF Cells 2006 ·Molecular Endocrinology ·George Vlotides, (unknown), Tamar Rubinek, Tamar Eigler, Christoph J. Auernhammer, Шломо Мелмед	35
17	SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29 2005 ·Biochemical and Biophysical Research Communications ·Stephan Brand, Kathrin Zitzmann, Julia Dambacher, Florian Beigel, Torsten Olszak, George Vlotides, Sören T. Eichhorst, Burkhard Göke, Helmut M. Diepolder, Christoph J. Auernhammer	74
18	Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3) / cardiotrophin-like cytokine (CLC)—a novel gp130 cytokine with pleiotropic functions 2004 ·Cytokine & Growth Factor Reviews ·George Vlotides, Kathrin Zitzmann, Günter K. Stalla, Christoph J. Auernhammer	28
19	SOCS-1 and SOCS-3 inhibit IFN-α-induced expression of the antiviral proteins 2,5-OAS and MxA 2004 ·Biochemical and Biophysical Research Communications ·George Vlotides, (unknown), Florian Kopp, Kathrin Zitzmann, Neziha Cengic, Stephan Brand, Roman Zachoval, Christoph J. Auernhammer	112
20	The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells 2004 ·Journal of Endocrinology ·(unknown), (unknown), George Vlotides, (unknown), Florian Kopp, (unknown), Neziha Cengic, D. Engelhardt, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact